N.J. A.G. Platkin, Division of Consumer Affairs Announce New Rules Aimed at Promoting Greater Transparency in Prescription Drug Pricing, Including How and Why Prices Are Increased
October 17, 2024
October 17, 2024
TRENTON, New Jersey, Oct. 17 -- New Jersey Attorney General Matthew J. Platkin issued the following news release on Oct. 16, 2024:
Advancing the Murphy Administration's efforts to rein in the high cost of prescription drugs in New Jersey, Attorney General Matthew J. Platkin and the Division of Consumer Affairs ("Division") today announced specially adopted new rules promoting greater transparency in prescription drug pricing.
The new rules, which became effect . . .
Advancing the Murphy Administration's efforts to rein in the high cost of prescription drugs in New Jersey, Attorney General Matthew J. Platkin and the Division of Consumer Affairs ("Division") today announced specially adopted new rules promoting greater transparency in prescription drug pricing.
The new rules, which became effect . . .